Perhaps, high-dose EPO might not only intervene the process of multiorgan dysfunction due to sepsis (Table 4) but also ameliorate the course in less reserved renal function backgrounds (Table 5), consistent with the observation that hemodialysis patients with COVID-19—a sepsis-like syndrome—are likely to develop less severe pneumonia [59]. This evidence concerns the gene EPO and pneumonia.